SCHEMBL13097075

SCHEMBL13097075

Cc1cc(O)c(-c2c(C)cc(-n3cc(Cl)cn3)cc2C)c(=O)o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.37
ALDH1A1 P00352 8/20 0.37
KMT2A Q03164 7/20 0.37
KDM4E B2RXH2 5/20 0.37
MEN1 O00255 5/20 0.37
GAA P10253 5/20 0.36
CYP1A2 P05177 4/20 0.36
CYP2C19 P33261 4/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
ALOX12 P18054 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
HPGD P15428 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 2/20 0.35
STAT6 P42226 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 3/20 0.35
TDP1 Q9NUW8 3/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13097105 0.73 ABL1 (0.37) MAPTALDH1A1KMT2AKDM4EGAA
SCHEMBL12401973 0.72 MEN1 (0.46) MAPTALDH1A1KMT2AKDM4EMEN1
SCHEMBL13097086 0.71 ALDH1A1 (0.30) MAPTALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL13097112 0.71 ALDH1A1 (0.34) MAPTALDH1A1KMT2AKDM4EGAA
SCHEMBL13527164 0.70 ANTXR2 (0.40) MAPTALDH1A1KMT2AKDM4EMEN1
SCHEMBL13097093 0.69 EGLN1 (0.31) MAPTALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL13176552 0.68 CYP3A4 (0.31) ALDH1A1CYP3A4
SCHEMBL13097099 0.68 MAPT (0.38) MAPTALDH1A1KMT2AKDM4EMEN1
SCHEMBL13097077 0.68 SMN1; SMN2 (0.38) MAPTALDH1A1KMT2AKDM4EMEN1
SCHEMBL13097078 0.68 CCR1 (0.31) ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS FISCHER REINER 2010-10-21 US disclosed
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS FISCHER REINER 2010-10-21 US disclosed
US-7776791-B2 N-heterocyclyl phenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2010-08-17 US disclosed
US-7776791-B2 N-heterocyclyl phenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2010-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS CYP17A1, CCNY, CCNE2 MAPT 4552/4885ALDH1A1 2486/4885KMT2A 1673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.